Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
AI-assisted anti-seizure medication selection? A qualitative study of the views of neurologists and epilepsy patients
2
Zitationen
6
Autoren
2025
Jahr
Abstract
PWE and neurologists were supportive of the prospects for MLCDS systems to improve ASM selection for people with epilepsy. However, their support was not unqualified and was often predicated on claims about the nature and role of these systems that are highly contested in the larger literature on the use of machine learning in medicine. In particular, the idea that systems that perform better than clinicians will remain sources of "advice", that machine learning will free up clinicians' time for longer conversations with patients, and that medical artificial intelligence will be "explainable", are all controversial. Our results suggest that much work remains to be done to discover how best to introduce MLCDS into clinical settings without jeopardizing stakeholders' support for these systems.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.336 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.207 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.607 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.476 Zit.